Published in Blood on January 27, 2005
Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res (2008) 1.57
Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Cell (2012) 1.26
Challenges and promises for the development of donor-independent platelet transfusions. Blood (2013) 1.09
In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev (2010) 1.07
Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation. Blood (2011) 1.04
A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation. Genes Dev (2012) 0.96
Distinct functional effects for dynamin 3 during megakaryocytopoiesis. Stem Cells Dev (2011) 0.88
Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia. Clin Cancer Res (2013) 0.84
An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells. Mol Cancer Res (2011) 0.80
Transient endoreplication down-regulates the kinesin-14 HSET and contributes to genomic instability. Mol Biol Cell (2016) 0.78
Bone marrow pathology predicts mortality in chronic hemodialysis patients. Biomed Res Int (2015) 0.75
Recent developments in ex vivo platelet production. Cytotechnology (2016) 0.75
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol (2000) 4.30
Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol (2004) 3.18
Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol (1977) 1.79
Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost (2003) 1.47
Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood (2004) 1.32
Endomitosis of human megakaryocytes are due to abortive mitosis. Blood (1998) 1.31
Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol (1997) 1.27
Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol (2003) 1.22
Polyploidy and maturation of rat megakaryocytes. Blood (1968) 1.13
Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am J Pathol (2004) 1.12
Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth. Leukemia (1999) 1.11
Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors. Blood (2004) 1.07
Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood (1996) 1.06
Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells. J Cell Biol (2001) 1.06
Cholecystokinin-stimulated protein kinase C-delta kinase activation, tyrosine phosphorylation, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J Biol Chem (2003) 1.06
Are Src family kinases involved in cell cycle resumption in rat eggs? Reproduction (2004) 0.93
Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharm Des (2004) 0.92
Megakaryocytopoiesis: cellular aspects and regulation. Crit Rev Oncol Hematol (1995) 0.83
Repression of AIM-1 kinase mRNA as part of a program of genes regulated by Mpl ligand. Biochem Biophys Res Commun (2001) 0.80
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood (2013) 2.26
Economic rewards for blood donation: validity of the donor questionnaire as litmus test. Clin Chem (2013) 1.99
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma. J Clin Oncol (2009) 1.52
Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int (2014) 1.52
The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion (2010) 1.44
The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene (2002) 1.41
Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol (2003) 1.22
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood (2005) 1.18
Continuous measurement of oxygen consumption by pancreatic islets. Diabetes Technol Ther (2002) 1.17
Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med (2014) 1.11
A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Haematologica (2010) 1.10
FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10. Hum Hered (2003) 1.07
Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors. Blood (2004) 1.07
Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol (2011) 1.07
Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation (2002) 1.06
Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol (2004) 1.02
A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia. Leuk Lymphoma (2010) 1.02
Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker. Bioorg Med Chem (2013) 1.00
Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant (2002) 0.99
In vivo inactivation of MASTL kinase results in thrombocytopenia. Exp Hematol (2009) 0.98
Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood (2003) 0.98
BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia. Mol Cancer Ther (2013) 0.97
X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). Exp Hematol (2003) 0.96
Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma. Leuk Lymphoma (2012) 0.95
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial. Leuk Lymphoma (2009) 0.94
Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation. Exp Hematol (2005) 0.86
Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant (2009) 0.85
Human leukocyte antigen genetics and clinical features of self-treated patients on a gluten-free diet. J Clin Gastroenterol (2013) 0.84
A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. Blood Cells Mol Dis (2005) 0.83
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. J Hematol Oncol (2014) 0.82
Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation (2013) 0.82
Assessing the efficacy of kidney paired donation--performance of an integrated three-site program. Transplantation (2014) 0.81
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma. Lung Cancer (2006) 0.81
Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant (2003) 0.81
Human nerve growth factor receptor and cytosine deaminase fusion genes. Hum Gene Ther (2003) 0.81
Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation (2004) 0.81
Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies. Cell Transplant (2003) 0.79
A comparative evaluation of culture conditions for short-term maintenance (<24 hr) of human islets isolated using the Edmonton protocol. Cell Tissue Bank (2003) 0.78
Role of splenectomy in inherited thrombocytopenias. Blood (2004) 0.77
Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation. Transplantation (2014) 0.77
32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody. Transplantation (2016) 0.76
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation (2013) 0.76
The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection. Transplantation (2014) 0.75
Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians. Transplantation (2016) 0.75
Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol (2010) 0.75
The post-platelet 100,000 count: effects of platelet collection and future. J Clin Apher (2010) 0.75
Targeted Next-Generation Sequencing for Human Leukocyte Antigen Typing in a Clinical Laboratory: Metrics of Relevance and Considerations for Its Successful Implementation. Arch Pathol Lab Med (2017) 0.75
Desensitization in the era of kidney paired donation: the Mayo Foundation 3-site experience. Clin Transpl (2013) 0.75
Transfusion medicine illustrated. Thrombus formation during platelet donation. Transfusion (2009) 0.75
Filter failures with sickling hemoglobin. Transfusion (2009) 0.75
Cord blood units collected at a remote site: a collaborative endeavor to collect umbilical cord blood through the Hawaii Cord Blood Bank and store the units at the Puget Sound Blood Center. Transfusion (2004) 0.75